Shenzhen Lifotronic Technology Co., Ltd. (688389.SS)
CNY 15.22
(0.33%)
CNY 15.22
(0.33%)
| Year | Net Debt | Net Debt Growth |
|---|---|---|
| 2023 | -1.06 Billion CNY | -33.43% |
| 2022 | -799.03 Million CNY | 0.69% |
| 2021 | -804.57 Million CNY | 4.52% |
| 2020 | -842.65 Million CNY | -2.84% |
| 2019 | -819.35 Million CNY | -58.56% |
| 2018 | -516.73 Million CNY | -4.66% |
| 2017 | -493.72 Million CNY | -20.25% |
| 2016 | -410.58 Million CNY | 0.0% |
| Year | Net Debt | Net Debt Growth |
|---|---|---|
| 2024 Q2 | -1.03 Billion CNY | 4.75% |
| 2024 Q1 | -1.08 Billion CNY | -1.69% |
| 2024 Q3 | -1.1 Billion CNY | -7.27% |
| 2023 Q4 | -1.06 Billion CNY | -22.24% |
| 2023 Q1 | -864.14 Million CNY | -8.15% |
| 2023 FY | -1.06 Billion CNY | -33.43% |
| 2023 Q2 | -791.86 Million CNY | 8.36% |
| 2023 Q3 | -872.13 Million CNY | -10.14% |
| 2022 FY | -799.03 Million CNY | 0.69% |
| 2022 Q4 | -799.03 Million CNY | -14.29% |
| 2022 Q3 | -699.09 Million CNY | -2.85% |
| 2022 Q2 | -679.7 Million CNY | 4.09% |
| 2022 Q1 | -708.69 Million CNY | 11.92% |
| 2021 Q1 | -678.65 Million CNY | 19.46% |
| 2021 Q2 | -609.7 Million CNY | 10.16% |
| 2021 Q3 | -640.79 Million CNY | -5.1% |
| 2021 FY | -804.57 Million CNY | 4.52% |
| 2021 Q4 | -804.57 Million CNY | -25.56% |
| 2020 Q4 | -842.65 Million CNY | -15.18% |
| 2020 Q1 | -537.6 Million CNY | 34.39% |
| 2020 FY | -842.65 Million CNY | -2.84% |
| 2020 Q2 | -634.19 Million CNY | -17.97% |
| 2020 Q3 | -731.61 Million CNY | -15.36% |
| 2019 Q2 | -456.55 Million CNY | -188.35% |
| 2019 FY | -819.35 Million CNY | -58.56% |
| 2019 Q3 | -327.91 Million CNY | 28.18% |
| 2019 Q1 | 516.73 Million CNY | 200.0% |
| 2019 Q4 | -819.35 Million CNY | -149.86% |
| 2018 FY | -516.73 Million CNY | -4.66% |
| 2018 Q4 | -516.73 Million CNY | 0.0% |
| 2017 FY | -493.72 Million CNY | -20.25% |
| 2016 FY | -410.58 Million CNY | 0.0% |
| Name | Net Debt | Net Debt Difference |
|---|---|---|
| Chison Medical Technologies Co., Ltd. | -678.43 Million CNY | -57.144% |